Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Farmers Insurance
Deloitte
Merck
Express Scripts
Chinese Patent Office
AstraZeneca
QuintilesIMS
US Army
Cerilliant

Generated: January 22, 2018

DrugPatentWatch Database Preview

LITHIUM CITRATE Drug Profile

« Back to Dashboard

Which patents cover Lithium Citrate, and when can generic versions of Lithium Citrate launch?

Lithium Citrate is a drug marketed by West-ward Pharms Int and Wockhardt and is included in two NDAs.

The generic ingredient in LITHIUM CITRATE is lithium citrate. There are fifteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the lithium citrate profile page.
Drug patent expirations by year for LITHIUM CITRATE
Pharmacology for LITHIUM CITRATE
Drug ClassMood Stabilizer

US Patents and Regulatory Information for LITHIUM CITRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int LITHIUM CITRATE lithium citrate SYRUP;ORAL 018421-001 Approved Prior to Jan 1, 1982 AA RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wockhardt LITHIUM CITRATE lithium citrate SYRUP;ORAL 070755-001 May 21, 1986 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
Healthtrust
Cipla
Chinese Patent Office
Citi
Cantor Fitzgerald
Novartis
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot